Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |